Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
Val8-glucagon-like peptide-1 protects against A140-induced impairment of hippocampal late-phase long-term potentiation and spatial learning in rats
Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
It is primarily used to treat certain medical conditions and promote overall well-being
proteinprotein interaction inhibitor Molecular Formula: C228H388N86O64 Molecular Weight: 5358.05 g/mol Appearance: White to off-white lyophilised powder Purity: 98.5 % (HPLC, typical) Solubility: Soluble in water and buffered aqueous solutions Storage: 20 C, desiccated, protected from light Pack Size: 10mg Description & Mechanism FOXO4-DRI is a synthetic, modified peptide derived from regions of the Forkhead box O4 (FOXO4) transcription factor
